Oral Bioavailability of Solid Formulation of GLPG1837 With and Without Food
NCT02562859
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
12
Enrollment
INDUSTRY
Sponsor class
Conditions
Healthy
Interventions
DRUG:
500 mg GLPG1837 as oral suspension
DRUG:
500 mg GLPG1837 as oral tablet
Sponsor
Lakefront Biotherapeutics NV